[Efficiency and safety of magnesium sulfate treatment in obstetrics].
Current views on efficacy and safety of magnesium sulfate treatment in obstetrics are presented. Negative effects of MgSO4 on fetus and newborn are described. Contradictory reports dealing with tocolytic efficacy of magnesium sulfate are discussed.
Zakładu Biochemii i Chemii Pomorskiej Akademii Medycznej w Szczecinie.
Wioletta
W
Mikołajek
Dariusz
D
Chlubek
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D006801:Humans; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000009:adverse effects / Q000627:therapeutic use*; D008431:Maternal-Fetal Exchange; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D015149:Tocolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D015149:Tocolytic Agents; D008278:Magnesium Sulfate